NasdaqCM - Delayed Quote • USD
STRATA Skin Sciences, Inc. (SSKN)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 5:23 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.07 | -0.05 | -0.19 | -0.1 |
| Low Estimate | -0.07 | -0.05 | -0.19 | -0.1 |
| High Estimate | -0.07 | -0.05 | -0.19 | -0.1 |
| Year Ago EPS | -0.08 | -0.09 | -0.31 | -0.19 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 6.91M | 7.62M | 31.79M | 34.77M |
| Low Estimate | 6.35M | 7.04M | 30.08M | 32.48M |
| High Estimate | 7.47M | 8.2M | 33.5M | 37.06M |
| Year Ago Sales | 7.5M | 8.25M | 18.46M | 31.79M |
| Sales Growth (year/est) | -7.90% | -7.60% | 72.20% | 9.40% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.07 | -0.05 | -0.04 | -0.02 |
| EPS Actual | -0.08 | -0.09 | -0.03 | -0.11 |
| Difference | -0.01 | -0.04 | 0.01 | -0.09 |
| Surprise % | -14.30% | -80.00% | 25.00% | -450.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.07 | -0.05 | -0.19 | -0.1 |
| 7 Days Ago | -0.07 | -0.05 | -0.19 | -0.1 |
| 30 Days Ago | -0.04 | -0.02 | -0.14 | 0.06 |
| 60 Days Ago | -0.04 | -0.02 | -0.14 | 0.06 |
| 90 Days Ago | -0.04 | -0.02 | -0.14 | 0.06 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | SSKN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 12.50% | -- | -- | 1.60% |
| Next Qtr. | 44.40% | -- | -- | 10.50% |
| Current Year | 38.70% | -- | -- | 5.20% |
| Next Year | 47.40% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 25.00% | -- | -- | 11.22% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Reiterates | CG Capital: Outperform | 5/16/2023 |
| Upgrade | HC Wainwright & Co.: Neutral to Buy | 11/3/2020 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 3/17/2020 |
| Initiated | Ladenburg Thalmann: Buy | 12/9/2019 |
| Initiated | Oppenheimer: Outperform | 11/21/2019 |
| Initiated | Northland Capital Markets: Outperform | 12/10/2018 |
Related Tickers
LUDG Ludwig Enterprises, Inc.
0.2450
+6.52%
AXDX Accelerate Diagnostics, Inc.
0.8590
+11.56%
SILK Silk Road Medical, Inc
17.32
-0.57%
LNSR LENSAR, Inc.
3.2300
+2.87%
ELUT Elutia Inc.
2.9100
+0.34%
TLIS Talis Biomedical Corporation
8.90
+1.95%
SGHT Sight Sciences, Inc.
5.13
-2.10%
SRDX Surmodics, Inc.
26.49
+0.38%
NMRD Nemaura Medical Inc.
0.1053
0.00%
SRTS Sensus Healthcare, Inc.
3.2900
+1.23%